These findings demonstrate that muscarinic M3 receptor blockade as well as β2-adrenoceptor stimulation is effective in reversing airway hyperresponsiveness of small intrapulmonary airways in COPD patients. Here, CHRM3 is linked to chronic obstructive pulmonary disease.